Intravenous iron reduced iron deficiency more effectively than oral iron, which is often distasteful, among pregnant women in Nigeria. However, no significant difference was found in the prevalence of ...

Among iron-deficient patients with heart failure with reduced ejection fraction (HFrEF), receiving intravenous iron supplementation was found to be safe but resulted in mixed findings, according to a ...

Shark Tank India's Namita Thapar recently shared a video of herself from her IV iron therapy. She talked about suffering from ...

The hematologic investigation of patients with fatigue often ends when a normal hemoglobin level is reported. However, some patients with normal hemoglobin might have other evidence of iron deficiency ...

IV iron dextran was the most cost-effective treatment, yielding 19.26 quality-adjusted life years at a cost of $157,500 vs 19.10 costing $152,900 for oral ferrous sulfate. HealthDay News — Intravenous ...

DENVER—Hemodialysis (HD) patients may be receiving excessive intravenous (IV) iron that could contribute to iron overload and toxicity in the long term, new data suggest. A team led by Ajay K. Singh, ...

Long-term treatment with iron administered intravenously improved symptoms and reduced recurrent hospitalizations among people with heart failure and iron deficiency, according to late-breaking ...

Among iron-deficient patients with heart failure with reduced ejection fraction (HFrEF), receiving intravenous iron supplementation was found to be safe but resulted in mixed findings, according to a ...

Investigators compared the therapies in a large national cohort of patients with normal kidney function. Intravenous (IV) vs oral iron therapy is not associated with a higher risk for new-onset ...

This prospective, multicenter, open-label, randomized trial enrolled 157 patients with chemotherapy-related anemia (Hb ≤ 105 g/L, serum ferritin ≤ 450 pmol/L or ≤ 675 pmol/L with transferrin ...

IV iron dextran is most cost-effective, yielding 19.26 QALYs compared with 19.10 QALYs for oral ferrous sulfate. (HealthDay News) — Intravenous (IV) iron dextran is the most cost-effective strategy ...